New release of Glioblastoma Atlas sheds light on deadly disease

May 14, 2015, Allen Institute for Brain Science

Robust new data added to the Ivy Glioblastoma Atlas Project (Ivy GAP) changes the scope and impact of this publicly available resource for researchers and clinicians searching for treatments for this most deadly and aggressive of brain cancers, glioblastoma multiforme.

Led by researchers at the Allen Institute for Brain Science and Swedish Neuroscience Institute and funded with a grant from The Ben and Catherine Ivy Foundation, Ivy GAP includes detailed information about genes expressed in the various anatomical regions of glioblastoma and important data about the presumed initial cancer stem cells that lead to tumor formation.

"This atlas has been a long-term partnership to provide a public resource for researchers worldwide to mine the data and identify trends that may lead to further studies and treatments," says Allan Jones, Ph.D., CEO of the Allen Institute.

"Our ultimate goal is to change the outcome for patients with this devastating disease," says Ralph Puchalski, Ph.D., scientist at the Allen Institute for Brain Science and co-Principal Investigator on the project. "The Ivy Glioblastoma Atlas Project is an unprecedented platform for exploring the anatomic and genetic basis of glioblastoma at the cellular and molecular levels. The atlas is an anatomic tour de force that is sure to provide vital information into how such tumors grow and invade healthy brain tissue."

"The need for projects like the Ivy Glioblastoma Atlas Project is urgent," said Catherine Ivy, president of The Ben and Catherine Ivy Foundation. "If we can give our medical leaders better research tools, we can move closer to our ultimate goal of curing glioblastoma."

"The Ivy Glioblastoma Project will advance the field by allowing investigators around the world to access massive amounts of tumor genomic information and patient clinical information," says Charles Cobbs, M.D., director of The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment at the Swedish Neuroscience Institute. "The new knowledge that will result from universal access to this amazing brain tumor atlas, originally envisioned by Dr. Greg Foltz at Swedish, will lead to advances in our understanding of the biology of glioblastoma, and may result in novel approaches to improve treatment and survival."

"Extensive studies of glioblastoma multiforme, the most aggressive brain cancer, have as a whole yielded limited treatment options and no cure," says Nameeta Shah, Ph.D., research scientist at The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment at the Swedish Neuroscience Institute and co- Principal Investigator on the project. "The Ivy Glioblastoma Atlas Project offers for the first time data for dissected by its distinct characteristic cell populations. This atlas will allow the worldwide research community to tackle this disease using a holistic approach, to understand its parts to put together a whole."

In 2006, Greg Foltz, M.D., approached the Allen Institute for Brain Science to create an openly available atlas of glioblastoma to accelerate the pace of research. The Allen Institute collaborated with The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment at the Swedish Neuroscience Institute, which Foltz founded with a grant from The Ben and Catherine Ivy Foundation, to create and share the atlas. In a tragic turn of events, Foltz died of pancreatic cancer shortly after his fiftieth birthday in 2013.

"Dr. Greg Foltz had a razor sharp focus in life: to cure brain cancer," says Shah. "Even during his own struggle with pancreatic cancer, he taught by example and made sure the scientists at the Ivy Center never lost focus and continued their efforts. The Ivy Glioblastoma Atlas Project is dedicated to him and will be his legacy."

The Phoenix-based Translational Genomics Research Institute (TGen) also applied its expertise in laser capture microdissection and RNA sequencing to the experimental design of Ivy GAP. TGen connected the Allen Institute for Brain Science with other neurosurgical groups for specimen accrual, as well as participated in recommending and prioritizing genes, focusing especially on those related to GBM invasion: the disease's propensity to stealthily move into adjoining areas of the brain.

"Understanding GBM invasion and heterogeneity allows us to look at how tumors adapt and change as they grow, helping identify the many enemies we are fighting—and treating them simultaneously," said Dr. Michael Berens, TGen Deputy Director for Research Resources, head of TGen's Glioma Research Lab, and a member of the Ivy GAP panel of domain experts.

Explore further: Study provides comprehensive look at brain cancer treatments

Related Stories

Study provides comprehensive look at brain cancer treatments

May 1, 2015
Led by the Translational Genomics Research Institute (TGen) and UC San Francisco (UCSF), a comprehensive genetic review of treatment strategies for glioblastoma brain tumors was published today in the Oxford University Press ...

Brain tumor patients put on fast track in revolutionary clinical trial

March 10, 2015
Brain tumor experts at Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center have launched a revolutionary fast-track approach to cancer research, giving new hope to brain cancer patients. ...

Team discovers mechanism responsible for tumor invasion in brain cancer

April 9, 2015
A neuro-oncology research team at Dartmouth's Norris Cotton Cancer Center, led by the Director Mark A. Israel, MD with first author Gilbert J. Rahme, PhD, recently identified the transcription factor Id4 as a suppressor of ...

Video: The chemistry of poison ivy

March 9, 2015
Leaves of three, let them be, right? But what happens when you get covered in poison ivy and can't stop scratching?

Research finds no correlation between regulatory T cells and survival in glioblastoma

April 16, 2015
Using a novel methodology of epigenetic quantitative analysis, Dartmouth-Hitchcock's Norris Cotton Cancer Center's interdisciplinary team of investigators led by Camilo Fadul, MD, found no correlation between regulatory T ...

Researchers identify protein pathway involved in brain tumor stem cell growth

February 26, 2015
Glioblastomas are a highly aggressive type of brain tumor, with few effective treatment options. Moffitt Cancer Center researchers are one step closer to understanding glioblastoma development following the identification ...

Recommended for you

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

A 150-year-old drug might improve radiation therapy for cancer

October 17, 2018
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer ...

Loss of protein p53 helps cancer cells multiply in 'unfavourable' conditions

October 17, 2018
Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development, according to new findings in eLife.

New method uses just a drop of blood to monitor lung cancer treatment

October 17, 2018
Dr. Tasuku Honjo won the 2018 Nobel Prize in physiology or medicine for discovering the immune T-cell protein PD-1. This discovery led to a set of anti-cancer medications called checkpoint inhibitors, one of the first of ...

Gene screening technique helps identify genes involved in a fatty liver-associated liver cancer

October 17, 2018
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack. This has certainly ...

Scientists zero in on ways to boost colorectal cancer screening

October 17, 2018
A comprehensive analysis by University of North Carolina Lineberger Comprehensive Cancer Center researchers evaluated more than 70 clinical studies to identify some of the most effective methods for boosting U.S. colorectal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.